nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)
|
Takizawa, Kohei |
|
|
24 |
2 |
p. 479-491 |
artikel |
2 |
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways
|
Su, Beibei |
|
|
24 |
2 |
p. 352-367 |
artikel |
3 |
Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer
|
Jung, Minoa K. |
|
|
24 |
2 |
p. 515-525 |
artikel |
4 |
Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system
|
Iwatsuki, Masaaki |
|
|
24 |
2 |
p. 526-534 |
artikel |
5 |
Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm
|
Yang, Hyo-Joon |
|
|
24 |
2 |
p. 435-444 |
artikel |
6 |
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
|
Fujitani, Kazumasa |
|
|
24 |
2 |
p. 477-478 |
artikel |
7 |
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging
|
Horiuchi, Yusuke |
|
|
24 |
2 |
p. 417-427 |
artikel |
8 |
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
|
Kurokawa, Yukinori |
|
|
24 |
2 |
p. 428-434 |
artikel |
9 |
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis
|
Molinari, Chiara |
|
|
24 |
2 |
p. 392-401 |
artikel |
10 |
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
|
Fujitani, Kazumasa |
|
|
24 |
2 |
p. 467-476 |
artikel |
11 |
Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer
|
Kim, So-Woon |
|
|
24 |
2 |
p. 327-340 |
artikel |
12 |
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
|
Jimenez-Fonseca, Paula |
|
|
24 |
2 |
p. 445-456 |
artikel |
13 |
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial
|
Iwasaki, Yoshiaki |
|
|
24 |
2 |
p. 492-502 |
artikel |
14 |
Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis
|
Cho, Hourin |
|
|
24 |
2 |
p. 283-291 |
artikel |
15 |
Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema
|
Shinohara, Hisashi |
|
|
24 |
2 |
p. 273-282 |
artikel |
16 |
Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns
|
Sentani, Kazuhiro |
|
|
24 |
2 |
p. 368-381 |
artikel |
17 |
MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer
|
Fujiya, Keiichi |
|
|
24 |
2 |
p. 341-351 |
artikel |
18 |
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands
|
Sugimoto, Ryo |
|
|
24 |
2 |
p. 382-391 |
artikel |
19 |
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer
|
Yamasaki, Makoto |
|
|
24 |
2 |
p. 535-543 |
artikel |
20 |
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
|
Zheng, Hualong |
|
|
24 |
2 |
p. 503-514 |
artikel |
21 |
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors
|
Kim, Yeun-Yoon |
|
|
24 |
2 |
p. 457-466 |
artikel |
22 |
Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation
|
Kim, Hee Jin |
|
|
24 |
2 |
p. 302-313 |
artikel |
23 |
SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis
|
Zhang, Liang |
|
|
24 |
2 |
p. 402-416 |
artikel |
24 |
The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study
|
Chang, Renin |
|
|
24 |
2 |
p. 292-301 |
artikel |
25 |
Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation
|
Pan, Yuanming |
|
|
24 |
2 |
p. 314-326 |
artikel |